miR-187 inhibits tumor growth and invasion by directly targeting MAPK12 in osteosarcoma

Chengliang Cui1, Xiaoyu Shi2

  • 1Department of Orthopedics, The First Affiliated Hospital of PLA General Hospital (304 Hospital), Beijing 100048, P.R. China.

Insights

MicroRNAs (miRNAs) are vital in cancer. This study found miR-187 is downregulated in osteosarcoma, inhibiting metastasis by targeting MAPK12, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators in cancer development and progression.
  • Dysregulation of specific miRNAs is implicated in various cancers, including osteosarcoma.
  • Understanding miRNA roles is crucial for identifying novel therapeutic targets.

Purpose of the Study:

  • To investigate the role of miR-187 in osteosarcoma.
  • To elucidate the regulatory relationship between miR-187 and MAPK12.
  • To explore the potential of the miR-187/MAPK12 axis in osteosarcoma metastasis.

Main Methods:

  • Quantitative polymerase chain reaction (qPCR) for miRNA expression analysis.
  • Transwell assays to assess cell migration and invasion.
  • Luciferase reporter assays to confirm direct miRNA-target interaction.

Main Results:

  • miR-187 expression was significantly decreased in osteosarcoma tissues and cell lines.
  • Low miR-187 levels correlated with advanced stage, lymph node metastasis, and deep stromal invasion.
  • miR-187 upregulation inhibited osteosarcoma cell migration and invasion in vitro.
  • MAPK12 was identified as a direct target of miR-187, with inverse expression patterns observed.

Conclusions:

  • miR-187 downregulation is a significant event in osteosarcoma progression.
  • The miR-187/MAPK12 pathway plays a critical role in osteosarcoma metastasis.
  • This pathway represents a potential novel therapeutic target for osteosarcoma treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K